A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 7, 2012, Pages 719-724

  Visser, Elizabeth M ^a   Wilde, Katie ^a   Wilson, James F ^b   Yong, Karl K ^c   Counsell, Carl E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GENERAL PRACTICE; HOSPITAL; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; UNITED KINGDOM;

EID: 84861856532     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-301546     Document Type: Article

References (37)

1. Sutherland JM. Observations on the prevalence of multiple sclerosis in Northern Scotland. Brain 1956;76:635-54.
2. Fog M, Hyllested K. Prevalence of disseminated sclerosis in the Faroes, the Orkneys and Shetland. Acta Neurol Scand 1966;42(Suppl 19):9-e.
3. Poskanzer DC, Walker AM, Yonkondy J, et al. Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands. Neurology 1976;26:14-7.
4. Poskanzer DC, Prenney LB, Sheridan JL, et al. Multiple sclerosis in the Orkney and Shetland Islands: I Epidemiology, clinical factors and methodology. J Epidemiol Community Health 1980;34:229-39. (Pubitemid 11207394)
5. Cook SD, Cromarty JI, Tapp W. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology 1985;35:545-51. (Pubitemid 15085074)
6. Cook SD, MacDonald J, Tapp W, et al. Multiple sclerosis in the Shetland Islands: an update. Acta Neurol Scand 1988;77:148-51. (Pubitemid 18069706)
7. Shepherd DI, Downie AW. Prevalence of multiple sclerosis in north-east Scotland. BMJ 1978;2:314-6.
8. Shepherd DI. Clinical features of multiple sclerosis in north-east Scotland. Acta Neurol Scand 1979;60:218-30. (Pubitemid 10193156)
9. Shepherd DI, Downie AW. A further prevalence study of multiple sclerosis in northeast Scotland. J Neurol Neurosurg Psychiatry 1980;43:310-5.
10. Phadke JG, Downie AW. Epidemiology of multiple sclerosis in the north-east (Grampian Region) of Scotlanddan update. J Epidemiol Community Health 1987;41:5-3.
11. Grant RM, Carver AD, Sloan RL. Multiple sclerosis in Fife. Scott Med J 1998;43:44-7. (Pubitemid 28221541)
12. Murray S, Bashir K, Penrice G, et al. Epidemiology of multiple sclerosis in Glasgow. Scott Med J 2004;49:100-4. (Pubitemid 39232584)
13. Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998;64:730-5. (Pubitemid 28274405)
14. Forbes RB, Wilson SV, Swingler RJ. The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist? J Neurol 1999;246:1033-40.
15. http://www.isdscotland.org/GPpracs&;pops (accessed 12 Jul 2011).
16. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31. (Pubitemid 13158528)
17. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
18. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6. (Pubitemid 41746873)
19. McWhirter RE, McQuillan R, Visser EM, et al. Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders. Eur J Hum Genet 2012;20:198-202.
20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis; an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1445-52.
21. http://www.gro-scotland.gov.uk/statistics/theme/population/estimates/ mid-year/2009/index.html (accessed 12 Jul 2011).
22. http://wwwn.cdc.gov/epiinfo/ (accessed 12 Jul 2011).
23. Altman DG, Machin D, Bryant TN, et al. Statistics with confidence. London: BMJ Books, 2000.
24. http://www.scotland.gov.uk/Topics/Statistics/Browse/Labour-Market/ TrendData/Q/EditMode/on/ForceUpdate/on (accessed 12 Jul 2011).
25. Poser CM, Brinar VV. Diagnostic criteria for multiple sclerosis: an historical review. Clin Neurol Neurosurg 2004;106:147-58. (Pubitemid 38716141)
26. Dean G, Kurtzke JF. On the risk of multiple sclerosis according to age at immigration to South Africa. BMJ 1971;3:725-9.
27. Bronnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004;127:844-50. (Pubitemid 38478529)
28. Kingwell E, van der Kop M, Zhao Y, et al. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada. J Neurol Neurosurg Psychiatry 2012;83:61-6.
29. http://www.gro-scotland.gov.uk/files2/stats/annual-review-2010 (accessed 11 Jan 2012).
30. Phadke JG. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland. J Neurol Neurosurg Psychiatry 1987;50:523-31. (Pubitemid 17067538)
31. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520-32.
32. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008;71:129-35.
33. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006;5:932-6. (Pubitemid 44556546)
34. Hammond SR, McLeod JG, Macaskill P, et al. Multiple sclerosis in Australia: socioeconomic factors. J Neurol Neurosurg Psychiatry 1996;61:311-3.
35. Kurtzke JF, Page WF. Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS. Neurology 1997;48:204-3.
36. Edwards PJ, Roberts I, Clarke MJ, et al. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev 2009;3:MR000008.
37. http://www.msr.scot.nhs.uk/data.html (accessed 22 Feb 2012).